Benesch, Friedlander, Coplan & Aronoff LLP Benesch, Friedlander, Coplan & Aronoff LLP
PeopleServices

Menu

  • People
  • Services
  • Resources
  • Locations
  • Careers
  • About
  • Contact
New Hampshire Joins Data Protection Trend, Passes Comprehensive Data Protection Law
  1. Resources
September 5, 2024

Tara Raghavan Quoted in Wall Street Journal Article on the FDA’s ‘Project Optimus’ Initiative

Media Mentions

Benesch Intellectual Property Partner Tara Raghavan was featured in The Wall Street Journal’s article, “FDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences.” Tara discussed the impact of the FDA's Project Optimus initiative, noting that it could extend the drug development process by six to twelve months, potentially increasing costs and challenges for smaller companies.

The article highlights the FDA’s efforts through Project Optimus to encourage drugmakers to re-evaluate cancer drug dosing to balance safety and efficacy better, aiming to reduce unnecessary side effects from high doses. However, some startups worry that the initiative could raise development time and costs, putting them at a disadvantage compared to larger competitors.

To read the full article, click here.

  • Tara Raghavan
    liamE
    312.624.6371
  • Intellectual Property
Stay Current. Sign up for our eAlerts
>
  • 2025 Benesch
  • Disclaimers
  • Privacy Policy
  • Related Sites
  • GDPR Statement
  • Terms
  • Client Payment Portal
  • Careers
Twitter
Facebook
LinkedIn